BAX/BAK-independent mitoptosis during cell death induced by proteasome inhibition?

Molecular Cancer Research

Volumn 7, Issue 8, 2009, Pages 1268-1284

  Lomonosova, Elena ^a   Ryerse, Jan ^a   Chinnadurai, G ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Edward A Doisy Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BH3 PROTEIN; BIM PROTEIN; PROTEASOME INHIBITOR; PROTEIN BAK; PROTEIN BAX; PROTEIN MCL 1; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL FUNCTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOPTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINASE INHIBITION; TRANSCRIPTION INITIATION; TRANSLATION REGULATION; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; HCT116 CELLS; HUMANS; LEUPEPTINS; MICE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PERMEABILITY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 69449097373     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0183     Document Type: Article

References (54)

1. Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer 2004;4:349-360
2. Nencioni A, Grunebach F, Patrone F, Ballestrero A, Brossart P. Proteasome inhibitors: antitumor effects and beyond. Leukemia 2007;21:30-36 (Pubitemid 44921831)
3. Lopes UG, Erhardt P, Yao R, Cooper GM. p53-dependent induction of apoptosis by proteasome inhibitors. J Biol Chem 1997;272:12893-12896 (Pubitemid 27216701)
4. Chauhan D, Catley L, Li G, et al. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from bortezomib. Cancer Cell 2005;8:407-419 (Pubitemid 41579835)
5. Nawrocki ST, Carew JS, Dunner K, Jr., et al. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 2005;65:11510-11519
6. Concannon CG, Koehler BF, Reimertz C, et al. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway. Oncogene 2007;26:1681-1692 (Pubitemid 46426201)
7. Youle RJ, Strasser A. The BCL-2protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59.
8. Chipuk JE, Green DR. How do BCL-2proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 2008;18:157-164
9. Zhu H, Zhang L, Dong F, et al. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene 2005;24:4993-4999 (Pubitemid 41129103)
10. Qin JZ, Ziffra J, Stennett L, et al. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 2005;65:6282-6293 (Pubitemid 40994414)
11. Fernandez Y, Verhaegen M, Miller TP, et al. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 2005;65:6294-6304 (Pubitemid 40994415)
12. Green DR, Reed JC.Mitochondria and apoptosis. Science 1998;281:1309-1312
13. Skulachev VP. Programmed death phenomena: from organelle to organism. Ann N Y Acad Sci 2002;959:214-237
14. Skulachev VP, Bakeeva LE, Chernyak BV, et al. Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis. Mol Cell Biochem 2004;256-7:341-358
15. Arnoult D, Rismanchi N, Grodet A, et al. Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr Biol 2005;15:2112-2118 (Pubitemid 41739743)
16. Tinari A, Garofalo T, Sorice M, Esposti MD, Malorni W. Mitoptosis: different pathways for mitochondrial execution. Autophagy 2007;3:282-284 (Pubitemid 46752699)
17. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989-992 (Pubitemid 30813268)
18. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-1501 (Pubitemid 28538613)
19. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001;8:739-758 (Pubitemid 32752454)
20. MacLaren AP, Chapman RS, Wyllie AH, Watson CJ. p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ 2001;8:210-218
21. Bunz F, Hwang PM, Torrance C, et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999;104:263-269
22. LeBlanc H, Lawrence D, Varfolomeev E, et al. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002;8:274-281 (Pubitemid 34250106)
23. Theodorakis P, Lomonosova E, Chinnadurai G. Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res 2002;62:3373-3376 (Pubitemid 34651381)
24. Bingle CD, Craig RW, Swales BM, Singleton V, Zhou P, Whyte MK. Exon skipping in Mcl-1 results in a bcl-2homology domain 3 only gene product that promotes cell death. J Biol Chem 2000;275:22136-22146 (Pubitemid 30621794)
25. Bae J, Leo CP, Hsu SY, Hsueh AJ. MCL-1S, a splicing variant of the antiapoptotic BCL-2family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem 2000;275:25255-25261 (Pubitemid 30687021)
26. Chipuk JE, Green DR. Dissecting p53-dependent apoptosis. Cell Death Differ 2006;13:994-1002.
27. Mathai JP, Germain M, Marcellus RC, Shore GC. Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene 2002;21:2534-2544 (Pubitemid 34438106)
28. Hershko T, Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 2004;279:8627-8634 (Pubitemid 38295917)
29. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-730 (Pubitemid 32385543)
30. Adams JM, Cory S. The Bcl-2apoptotic switch in cancer development and therapy. Oncogene 2007;26:1324-1337 (Pubitemid 46328466)
31. Johnson DE. Noncaspase proteases in apoptosis. Leukemia 2000;14:1695-1703
32. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626-629
33. Scorrano L, Ashiya M, Buttle K, et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002;2:55-67. (Pubitemid 34065906)
34. Sugiyama T, Shimizu S, Matsuoka Y, Yoneda Y, Tsujimoto Y. Activation of mitochondrial voltage-dependent anion channel by a pro-apoptotic BH3-only protein Bim. Oncogene 2002;21:4944-4956 (Pubitemid 34888339)
35. Sun MG, Williams J, Munoz-Pinedo C, et al. Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis. Nat Cell Biol 2007;9:1057-1065 (Pubitemid 47628238)
36. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001;15:1481-1486 (Pubitemid 32552527)
37. Russo SM, Tepper JE, Baldwin AS, Jr., et al. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-κB. Int J Radiat Oncol Biol Phys 2001;50:183-193
38. Adams J. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer. Curr Opin Chem Biol 2002;6:493-500. (Pubitemid 34804773)
39. Hideshima T, Chauhan D, Richardson P, et al. NF-κB as a therapeutic target in multiple myeloma. J Biol Chem 2002;277:16639-16647 (Pubitemid 34967682)
40. Mitsiades N, Mitsiades CS, Poulaki V, et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci U S A 2002;99:14374-14379 (Pubitemid 35257679)
41. Ding WX, Ni HM, Yin XM. Absence of Bax switched MG132-induced apoptosis to non-apoptotic cell death that could be suppressed by transcriptional or translational inhibition. Apoptosis 2007;12:2233-2244
42. Wolff S, Erster S, Palacios G, Moll UM. p53′s mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 2008;18:733-744 (Pubitemid 351948223)
43. Pietsch EC, Perchiniak E, Canutescu AA, Wang G, Dunbrack RL, Murphy ME. Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J Biol Chem 2008;283:21294-21304
44. Frank S, Gaume B, Bergmann-Leitner ES, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001;1:515-525 (Pubitemid 33586103)
45. Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 2005;280:35742-35750 (Pubitemid 41532767)
46. Jagasia R, Grote P, Westermann B, Conradt B. DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature 2005;433:754-760 (Pubitemid 40292985)
47. Germain M, Mathai JP, McBride HM, Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J 2005;24:1546-1556 (Pubitemid 40646445)
48. Delivani P, Adrain C, Taylor RC, Duriez PJ, Martin SJ. Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. Mol Cell 2006;21:761-773 (Pubitemid 43376127)
49. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002;2:183-192 (Pubitemid 41043974)
50. Kim H, Rafiuddin-Shah M, Tu HC, et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2subfamilies. Nat Cell Biol 2006;8:1348-1358 (Pubitemid 44835109)
51. Weber A, Paschen SA, Heger K, et al. BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2proteins. J Cell Biol 2007;177:625-636 (Pubitemid 46799834)
52. Lomonosova E, Subramanian T, Chinnadurai G. Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1-19K. Oncogene 2005;24:6796-6808 (Pubitemid 41487038)
53. Liu H, Ma Y, Pagliari LJ, et al. TNF-α-induced apoptosis of macrophages following inhibition of NF-κB: a central role for disruption of mitochondria. J Immunol 2004;172:1907-1915 (Pubitemid 38116841)
54. Colell A, Ricci JE, Tait S, et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007;129:983-997 (Pubitemid 46813151)